MedTrace Logo

Colorectal Cancer Screening Using Stool DNA-based SDC2 Methylation Test

NCT04304131 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1210

Last updated 2023-03-14

No results posted yet for this study

Summary

A study of colorectal cancer screening using stool DNA-based SDC2 methylation test

Conditions

Interventions

DIAGNOSTIC_TEST

Earlytect Colon Cancer

A diagnostic device measuring syndecan 2 methylation status in stool DNA to detect colorectal cancer

Sponsors & Collaborators

  • Genomictree, Inc.

    collaborator INDUSTRY

  • Kyung Hee University Hospital at Gangdong

    lead OTHER

Principal Investigators

  • Suk-Hwan Lee, MD, PhD · Kyung Hee University Hospital at Gangdong

  • Chang Woo Kim, MD, PhD · Ajou University School of Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-07
Primary Completion
2022-01-10
Completion
2022-01-10

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04304131 on ClinicalTrials.gov